United States Phlebotomy Equipment Industry to Cross US$ 5.8 Billion Mark by 2034 Amid Growing Demand for Blood Tests

United States Phlebotomy Equipment Industry

As per the latest analysis, the United States Phlebotomy Equipment Industry is set to be valued at US$ 4.2 billion in 2024. Overall sales of phlebotomy equipment in the nation will likely rise at 3.3% CAGR during the forecast period, totaling US$ 5.8 billion by 2034.

Demand for phlebotomy supplies is expected to grow at a higher CAGR of 3.9% during the forecast period. This is due to their indispensable role in facilitating safe, efficient, and standardized blood collection procedures essential for diagnostic and therapeutic purposes in healthcare settings.

Multiple factors are expected to drive growth of the phlebotomy equipment industry in the United States during the next ten years. These include rising prevalence of chronic diseases, increasing demand for blood tests, and innovation in phlebotomy devices.

Amid rising incidence of chronic diseases like diabetes across the United States, there is a surging demand for blood tests for diagnostic and treatment purposes. This will likely create a need for reliable and efficient phlebotomy equipment nationwide.

Growing interest in preventive healthcare is another key factor expected to boost phlebotomy equipment sales in the United States through 2034. Similarly, rise in blood donation camps will likely propel phlebotomy equipment demand during the assessment period.

Significant trends, including automation and the integration of medical devices, are propelling the industry into a maturity phase. Automation, particularly in blood collection processes, streamlines procedures, mitigates manual errors and reduces variability and sample loss.

Innovative technologies such as robotic venipuncture systems contribute to increased efficiency by standardizing protocols and shortening the time required for blood collection. This heightened efficiency enhances patient throughput and optimizes resource utilization within healthcare facilities.

The integration of phlebotomy equipment with digital health platforms and Electronic Health Record (EHR) systems marks a pivotal development. By capturing patient data in real-time, healthcare providers ensure the availability of accurate and up-to-date information for authorized professionals.

Request The Sample PDF Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-19256

Key Takeaways from the United States Phlebotomy Equipment Market Report

• The phlebotomy equipment industry revenue in the United States is set to total US$ 5.8 billion in 2034.
• Based on product, the phlebotomy supplies segment is expected to grow at a CAGR of 9% through 2034.
• In terms of usage, the disposable devices segment will likely account for a value share of 1% in 2024.
• By end-users, the hospitals segment is estimated to hold 25% of the United States phlebotomy equipment industry share in 2024.
• Northeast United States is expected to remain the most lucrative pocket for phlebotomy equipment manufacturers, exhibiting a CAGR of 8%.

“Rising awareness regarding the advantages of monitoring blood profile regularly and surge in blood donation across the United States are anticipated to uplift demand for phlebotomy equipment during the forecast period,” says a lead Future Market Insights (FMI) analyst.

Who is Winning?

Cardinal Health, BD, Terumo Corporation, SARSTEDT AG & Co. KG, Medline Industries, LP., Heathrow Scientific, Marketlab, Kawasumi Laboratories America, United Metal Fabricators, Inc., Hill Laboratories Company, Clinton Industries, Inc., Brandt Industries, B. Braun Medical Inc., NIPRO, and STRECK are few leading phlebotomy equipment manufacturers listed in the report.

Key players are constantly innovating to develop safe and efficient phlebotomy products. They are also showing inclination towards employing strategies like partnerships, collaborations, acquisitions, and distribution agreements to stay ahead of the competition.

United States Phlebotomy Equipment Market Recent Development:

• In December 2023, Becton, Dickinson, and Company (BD) received 510(k) clearances from the US Food and Drug Administration (FDA) for its latest fingertip blood collection tool, the BD MiniDraw Capillary Blood Collection System.

Want More Insights?

Future Market Insights (FMI) brings a comprehensive research report on projected revenue growth in the United States and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. The United States phlebotomy equipment industry is segmented in detail to cover every aspect of the business and present a complete intelligence approach to the reader.

The study provides compelling insights into phlebotomy equipment industry based on product (phlebotomy supplies (syringes, blood collection needles, blood draw trays, evacuated collection tubes, tourniquets, non-sterile gloves, scrubs, gauze or bandages, blood safety lancets, and alcohol pads), phlebotomy carts, phlebotomy cabinets, phlebotomy chairs and phlebotomy tables),  usage (disposable and reusable devices), and end-user (hospitals, ambulatory, surgical centers, diagnostic laboratories, skilled nursing facilities, long term care centers, specialty clinics, blood banks, home healthcare providers and others), across the United States.

Purchase The Full Report Now!
https://www.futuremarketinsights.com/checkout/19256

United States Phlebotomy Equipment Market Segmentation

By Product:

• Phlebotomy Supplies
  • Syringes
  • Blood Collection Needles
  • Blood Draw Trays
  • Evacuated Collection Tubes
  • Tourniquets
  • Non-sterile Gloves
  • Scrubs
  • Gauze or Bandages
  • Blood Safety Lancets
  • Alcohol Pads
• Phlebotomy Carts
• Phlebotomy Cabinets
• Phlebotomy Chairs
• Phlebotomy Tables

By Usage:

• Disposable Devices
• Reusable Devices

By End-user:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Skilled Nursing Facilities
• Long Term Care Centers
• Specialty Clinics
• Blood Banks
• Home Healthcare Providers
• Others

By Region:

• Northeast United States
• Midwest United States
• Southeast United States
• Southwest United States
• West United States

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube